Pharmaceuticals & Therapuetics, Product & Vendor Updates

QUVIVIQ Wins Best Biotechnology & Pharmaceutical Product

Idorsia Ltd announces that its novel treatment for insomnia disorder QUVIVIQ (Daridorexant) has been awarded the inaugural Prix Galien Bridges Award in the category of “Best Biotechnology & Pharmaceutical Product”. The award recognizes groundbreaking medicines, including biologics, gene therapies, and traditional pharmaceutical compounds, that advance patient care through scientific innovation. […]

Central Sleep Apnea, CPAP & Interfaces, Obstructive Sleep Apnea, PAP & Ventilation, Product & Vendor Updates, Sleep Disorders

FDA Clears Kricket Positive Airway Pressure Device with KPAP

SleepRes, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Kricket PAP device, powered by Kairos Positive Airway Pressure (KPAP)™ for the treatment of obstructive sleep apnea (OSA) in patients weighing more than 66 lbs. The SleepRes PAP system is intended for home, hospital/institutional, […]

ARTICLES, Clinical Testing & Diagnostics, HST, Polysomnography

The Future is Hybrid: Blending In-lab Expertise With Remote Diagnostics

All around the world, sleep specialists are facing the same reality: the burden of sleep disorders is growing. And patients increasingly need faster, more flexible access to high-quality diagnostics and treatment.  In Germany, where we are based, the cost of sleep disorders has risen nearly 50% in less than a […]

AASM, Patient Care & Sleep Health

Scrolling for Sleep: The Social Media Trends Impacting Americans’ Sleep Habits

Social media trends have become increasingly influential – even changing bedtime routines and sleep habits for many Americans. According to a 2025 survey from the American Academy of Sleep Medicine, 56% of U.S. adults have tried one of this year’s viral social media trends related to sleep. “Bed rotting,” which is […]